Wet Cupping
ProcedureParticipants assigned to the treatment group will receive wet-cupping therapy 3 times per week for 2 weeks
Other names: Hijamah
NCT Number: NCT02012205
Background: Persistent nonspecific low back pain (PNSLBP) is one of the most common low back pains worldwide. Many interventions were tried including wet cupping which is commonly used for pain conditions in Saudi Arabia and other parts in the world but without solid scientific evidence.
Aims: This study aims at determining safety and efficacy of wet cupping for treating PNSLBP.
Methods: This is a randomized wait-listed controlled clinical trial. Eligible patients with history of at least 3 months of PNSLBP will be randomized in to two groups, 45 patients each. The first group will be given wet-cupping treatment at two acupuncture points of urinary Bladder (BL) meridians among the BL23, BL24 and BL25, 6 times within 2 weeks. The second group will serve as a control group. Usual care, including providing brochures for exercise, general advice for PNSLBP and acetaminophen, will be allowed in both groups. Separate assessors participated in the outcome assessment. Investigators will use the 0 to100 numerical rating scale (NRS) for pain, the McGill Pain questionnaire for pain intensity (PPI) and the Oswestry Disability Questionnaire (ODQ), and to assess acetaminophen use and safety issues.
Expected Results: To provide data on the safety and effectiveness of wet cupping in treating PNSLBP and open the way for integrative medicine in Saudi Arabia
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
King Fahad Specialist Hospital, Jeddah, Saudi Arabia
Objectives:
To evaluate the effectiveness of wet cupping in the treatment of NSLBP:
I-To compare Functioning (Oswestry Disability Questionnaire) from the base to the end of the two weeks of wet cupping sessions& two weeks later in the two groups II-To compare NRS from base to two weeks after the end of cupping III-To compare Number of Acetaminophen tables taken at the end of two weeks. IV-To evaluate Safety of wet cupping
SPECIFIC HYPOTHESIS: The hypothesis of this study is that the improvement of Numeric Rating Scale (NRS) for Pain at the end of the study will be greater in the Wet Cupping Treatment group than in the Control group
Overall Design: a randomised, waiting-list controlled, open-label, parallel trial.
Case definition parameters:
Study Design:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2-Patients who are inappropriate to the wet cupping treatment.
3-Patients who have experiences of wet cupping treatment during last 3 months. 4-Patients who have had treatment for low back pain during last 2 weeks. 5-Patients who are in pregnancy or have plan to conception. 6-Patients who have vertebra surgery or have plan of surgery.
Participants assigned to the treatment group will receive wet-cupping therapy 3 times per week for 2 weeks
Other names: Hijamah
Time frame: at the end of the two weeks wet cupping sessions.
Difference in Numeric Rating Score at the base and at the end of two weeks of cupping sessions.
Time frame: at the end of two weeks of cupping sessions and two weeks later
Change in the score from base line
Time frame: at the end of two weeks of cupping sessions and two weeks later
change in the score from the base line
Time frame: at the last visit, one week after the end of the last sessions
Differences in number of participants with Serious and Non-Serious Adverse Events.
National Center for Complementary and Alternative Medicine, Saudi Arabia
Other Gov
Safety and Efficacy of Wet Cupping on Persistent Non-specific Low Back Pain: A Randomized, Controlled, Open-label, Parallel-group
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.